Ram Pradhum, Penalver Jorge L, Lo Kevin Bryan U, Rangaswami Janani, Pressman Gregg S
Tex Heart Inst J. 2019 Feb 1;46(1):21-27. doi: 10.14503/THIJ-17-6562. eCollection 2019 Feb.
Carcinoid heart disease is the collective term for all cardiac manifestations in patients who have carcinoid syndrome. Carcinoid heart disease has a multifactorial pathophysiology, and the right side of the heart is usually involved. Symptoms and signs vary depending upon the affected cardiac components; most typical is right-sided heart failure secondary to diseased tricuspid and pulmonary valves. Despite no single ideal diagnostic test, strong suspicion, coupled with serologic and imaging results, usually enables diagnosis. Advances in imaging, such as speckle-tracking echocardiography and cardiac magnetic resonance, have improved the diagnostic yield. Treatment is challenging, warrants a multidisciplinary approach, and can be medical or surgical depending on the cardiac manifestations. Investigators are exploring the therapeutic use of monoclonal antibodies and new somatostatin analogues. In this review, we cover current knowledge about the pathophysiology, diagnosis, and treatment of carcinoid heart disease.
类癌性心脏病是指患有类癌综合征患者的所有心脏表现的统称。类癌性心脏病具有多因素病理生理学,心脏右侧通常受累。症状和体征因受影响的心脏组件而异;最典型的是继发于病变三尖瓣和肺动脉瓣的右侧心力衰竭。尽管没有单一理想的诊断测试,但强烈的怀疑加上血清学和影像学结果通常能够确诊。成像技术的进步,如斑点追踪超声心动图和心脏磁共振成像,提高了诊断率。治疗具有挑战性,需要多学科方法,并且根据心脏表现可采用药物或手术治疗。研究人员正在探索单克隆抗体和新型生长抑素类似物的治疗用途。在本综述中,我们涵盖了有关类癌性心脏病病理生理学、诊断和治疗的当前知识。